Immunogenicity of Guselkumab (GUS) Among Psoriasis Patients in VOYAGE (VOY) 1&2 Studies. J of Skin [Internet]. 2022 Mar. 4 [cited 2026 May 22];6(2):s11. Available from: https://skin.dermsquared.com/skin/article/view/1528